For its expression in each sample, C9orf16 was almost nondetectable in any normal samples, but the expression levels were dramatically increased in all the primary cancer cells and the expression levels were further upregulated in metastatic cancer cells (Fig. 3C). This evidence concerns the gene BBLN and metastatic malignant neoplasm.